Angiology · 2008 · 15 citations · 32 references
MedicineCardiologyClinical SciencesClinical CardiologyDiabetologyVascular SurgeryCardiovascular DiseaseMetabolic EvaluationMetabolic SyndromePeripheral Arterial DiseaseAtherosclerotic Peripheral DiseaseAtherosclerotic Risk AssessmentC-reactive Protein TestingMetabolic Syndrome AssociationsMetabolic Syndrome EpidemiologyMetabolic Syndrome Risk AssessmentMetabolic Syndrome ScreeningPeripheral Artery Disease Assessment
The aim of this cross-sectional study was to determine the prevalence of metabolic syndrome (MetS) and its components among 100 patients with progressive peripheral arterial disease (PAD) referred for diagnostic angiography in preparation for a revascularization procedure. The prevalence of MetS was more than 95%. Diabetes mellitus was the most prevalent component followed by hypertension and low high-density lipoprotein. Almost half the patients aggregated in the highest metabolic score category. A direct relationship was identified between the number of MetS components and serum uric acid (P = .001) and C-reactive protein (P = .826), whereas an inverse relationship was seen between the clustering of components and androgen levels in men (P < .001). For PAD, which could have a benign clinical course, early screening for MetS might identify those at greater risk of failing conservative therapy and progressing to a more aggressive atherosclerotic disease typically associated with high morbidity and mortality.
32
Prevalence of the Metabolic Syndrome Among US Adults
Earl S. Ford, Wayne H. Giles, William H. Dietz · JAMA · 2002 · 6.7K citations
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Bo Isomaa, Peter Almgren, Björn Forsén et al. · Diabetes Care · 2001 · 4.8K citations
Medicine, Endocrinology, Diabetology +15
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
Paul M. Ridker, Julie E. Buring, Nancy R. Cook et al. · Circulation · 2003 · 2.3K citations